Latest Medicare News news from across the web.
Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News .
Read full article →What should life sciences investors and targets focus on for dealmaking success? Here are six actionable steps. The post Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges appeared first on MedCity News .
Read full article →Here’s what healthcare entities should know about the maturing landscape, what to actually be concerned about, and the next stage of healthcare data evolution as we know it. The post Are We Entering an Interoperability Trust Recession? appeared first on MedCity News .
Read full article →KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
Read full article →Juno Bio’s funding was supported by Ada Ventures, Artesian, Entrepreneur First and Illumina Accelerator. The post Juno Bio Raises $3.8M to Support Vaginal Health appeared first on MedCity News .
Read full article →HSS chief digital and information officer Ashis Barad, who has worked on both the payer and provider sides of healthcare AI, thinks the industry’s growing “bot vs. bot” battle over prior authorizations and appeals is driving costs up. To him, the real fix lies in providers and payers sharing data to build more personalized care pathways. The post The ‘Bot Vs. Bot’ Dynamic Between Providers & Payers Is Driving Up Costs for Everyone appeared first on MedCity News .
Read full article →GSK said the mixed Phase 3 results for camlipixant mean this pill “is unlikely to transform patient care” in recurrent chronic cough. GSK is stopping work in this indication, a setback to a program once hoped to yield a new blockbuster product for the company’s respiratory drug portfolio. The post GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough appeared first on MedCity News .
Read full article →The opportunity ahead is to treat physician well-being as a core strategic priority, measured with the same rigor and acted upon with the same urgency as any other critical performance domain. The post Why Specialty-Specific Measurement and Intervention Are Essential to Address Healthcare Burnout appeared first on MedCity News .
Read full article →KFF Health News’ Julie Rovner interviews Elizabeth Mitchell, the president and CEO of the Purchaser Business Group on Health, about systemic healthcare changes backed by large employers, which cover millions of Americans.
Read full article →Last year, the Trump administration announced a voluntary commitment by dozens of insurers to improve a process called prior authorization, which often requires patients or their doctors to seek approval before proceeding with treatment. Less than one year later, some insurers chose not to sign the pledge’s update.
Read full article →New 3D printed technology makes lower extremity surgeons architects of restoration, not adaptation. The post Why Settle for Acceptable Versus Optimal Outcomes? appeared first on MedCity News .
Read full article →President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, Erica Schwartz, expressed support for vaccines, including covid shots, in her confirmation hearing. It’s a distinction from health secretary Robert F. Kennedy Jr.
Read full article →